Kidney disease genetics and the importance of diversity in precision medicine

Pacific Symposium on Biocomputing

Volumn , Issue , 2016, Pages 285-296

  Bailey, Jessica N Cooke ^a   Wilson, Sarah ^b   Brown Gentry, Kristin ^c   Goodloe, Robert ^c   Crawford, Dana C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; GENES; HEALTH; RISK ASSESSMENT; SURVEYS;

CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURES; END STAGE RENAL DISEASE; LINKAGE DISEQUILIBRIUM; LOGISTIC REGRESSIONS; QUANTITATIVE MEASURES; SINGLE NUCLEOTIDE POLYMORPHISMS; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE;

ADULT; AFRICAN AMERICAN; BIOLOGY; CAUCASIAN; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENETICS; HEALTH DISPARITY; HUMAN; KIDNEY DISEASES; MALE; MEXICAN AMERICAN; MIDDLE AGED; NUTRITION; PERSONALIZED MEDICINE; PROCEDURES; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; COMPUTATIONAL BIOLOGY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HEALTH STATUS DISPARITIES; HUMANS; KIDNEY DISEASES; MALE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECISION MEDICINE; QUANTITATIVE TRAIT LOCI; UNITED STATES;

EID: 85012193835     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: 10.1142/9789814749411_0027     Document Type: Conference Paper

References (24)

1. Scott RP, Quaggin SE: The cell biology of renal filtration. The Journal of Cell Biology 2015, 209: 199-210.
2. USRDS Coordinating Center. United States Renal Data System. 2015. 7-24-2015.
3. Cowie CC, Port FK, Wolfe RA, SAVAGE PJ, Moll PP, Hawthorne VM: Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of Diabetes. N Engl J Med 1989, 321: 1074-1079.
4. Williams WW, Pollak MR: Health Disparities in Kidney Disease--Emerging Data from the Human Genome. N Engl J Med 2013, 369: 2260-2261.
5. Lipworth L, Mumma MT, Cavanaugh KL, Edwards TL, Ikizler TA, Tarone R et al.: Incidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites. PLoS ONE 2012, 7: e48407.
6. McClellan WM, Newsome BB, McClure LA, Howard G, Volkova N, Audhya P et al.: Poverty and Racial Disparities in Kidney Disease: The REGARDS Study. American Journal of Nephrology 2010, 32: 38-46.
7. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW et al.: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008, 40: 1175-1184.
8. Kao WHL, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M et al.: MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008, 40: 1185-1192.
9. Parsa A, Kao WHL, Xie D, Astor BC, Li M, Hsu Cy et al.: APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease. N Engl J Med 2013, 369: 2183-2196.
10. Melzer D, Perry JRB, Hernandez D, Corsi AM, Stevens K, Rafferty I et al.: A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs). PLoS Genet 2008, 4: e1000072.
11. Zemunik T, Boban M, Lauc G, Jankovic S, Rotim K, Vatavuk Z et al.: Genome-wide association study of biochemical traits in Korcula Island, Croatia. Croat Med J 2009, 50: 23-33.
12. Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS: A genome-wide association for kidney function and endocrine-related traits in the NHLBI’s Framingham Heart Study. BMC Med Genet 2007, 8: S10.
13. Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M et al.: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009, 41: 712-717.
14. Matise TC, Ambite JL, Buyske S, Carlson CS, Cole SA, Crawford DC et al.: The Next PAGE in Understanding Complex Traits: Design for the Analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. American Journal of Epidemiology 2011, 174: 849-859.
15. Oetjens M, Brown-Gentry K, Goodloe R, Dilks HH, Crawford DC. Population stratification in the context of diverse epidemiologic surveys (in preparation).
16. Bush WS, Boston J, Pendergrass SA, Dumitrescu L, Goodloe R, Brown-Gentry K et al.: Enabling high-throughput genotype-phenotype associations in the Epidemiology Architecture for Genes Linked to Environment (EAGLE) project as part of the Population Architecture using Genomics and Epidemiology (PAGE) study. Pac Symp Biocomput 2013, 18: 373-384.
17. Pendergrass S, Dudek SM, Roden DM, Crawford DC, Ritchie MD: Visual integration of results from a large DNA biobank (BioVU) using synthesis-view. Pac Symp Biocomput 2011, 265-275.
18. Pendergrass S, Dudek S, Crawford D, Ritchie M: Synthesis-View: visualization and interpretation of SNP association results for multi-cohort, multi-phenotype data and meta-analysis. BioData Mining 2010, 3: 10.
19. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467: 52-58.
20. Cooke JN, Bostrom MA, Hicks PJ, Ng MCY, Hellwege JN, Comeau ME et al.: Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrology Dialysis Transplantation 2012, 27: 1505-1511.
21. Quaggin SE, George AL: Apolipoprotein L1 and the Genetic Basis for Racial Disparity in Chronic Kidney Disease. Journal of the American Society of Nephrology 2011, 22: 1955-1958.
22. Anderson BR, Howell DN, Soldano K, Garrett ME, Katsanis N, Telen MJ et al.: In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress. PLoS Genet 2015, 11: e1005349.
23. Kohane IS: Ten things we have to do to achieve precision medicine. Science 2015, 349: 37-38.
24. Freedman BI, Julian BA: Should kidney donors be genotyped for APOL1 risk alleles?. Kidney Int 2015, 87: 671-673.